Alphatec raises 2026 adjusted EBITDA outlook to $140 million; Q2 revenue up 15%
Alphatec reported second-quarter 2026 revenue of $214 million, up 15% year-over-year, and a GAAP net loss of $26 million, narrower than $41 million a year earlier. The company raised its full-year 2026 adjusted EBITDA guidance to approximately $140 million from approximately $134 million and kept its revenue outlook of approximately $882 million.
Key points
- Q2 2026 total revenue of $214 million, up 15% year-over-year; surgical revenue of $196 million, up 17%
- GAAP net loss of $26 million in Q2 2026 versus $41 million in Q2 2025; non-GAAP net income of $11 million
- Adjusted EBITDA of $36 million, or 16.8% margin, versus $23 million in Q2 2025
- 2026 adjusted EBITDA guidance raised to approximately $140 million from $134 million; revenue outlook of approximately $882 million reaffirmed
The filing
Written by AI on Nov 9, 2026, 10:08 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 04, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.